CALIBRATE

By | March 10, 2017
Facebooktwittergoogle_pluslinkedin

The objective of the caLIBRAte project is to establish a state-of-the-art versatile Risk Governance framework for assessment and management of human and environmental risks of MN and MN-enabled products.

 

The framework will be a web-based “system-of-systems” linking different models and methods for:

  1. screening of apparent and perceived risks and trends in nanotechnology
  2. control banding, qualitative and fully integrated predictive quantitative risk assessment operational at different information levels
  3. safety-by-design and multi-criteria decision support
    methods
  4. risk surveillance, -management and -guidance documents.

The risk management framework will support assessments of emerging and existing MN and MN-enabled products following the recent ISO31000 risk governance framework, as well as safety in innovation by matching models to the principle innovation steps in the “Cooper Stage-Gate®” product innovation model.

 

Control banding tools and quantitative models will be subject to sensitivity analysis and performance testing followed by a revision as needed. After revision the models will again be analyzed by sensitivity testing, calibration, performance tested to establish the uncertainties. After calibration, the models will be part of the framework, which will be demonstrated by case studies. Stakeholders will be involved for defining the user requirements of the framework and will receive training in the framework at the end.

 

The caLIBRAte project proposal answers to the call of NMP30-2015: Next generation tools for risk governance of NMs. The project is specifically designed to address the key challenges defined in the scope of the call text. There is particular focus on model revision, calibration and demonstration of existing models and methods that support the risk governance framework in regards to safe innovation and already implemented nanomaterials. Next generation computational exposure assessment and – toxicology is anticipated in the framework.

 

Number of Contract: H2020/686239

 

Email LEITAT manager in charge: Max Viallon

 

Web: www.nanocalibrate.eu

 

Starts: 1st of May 2016

 

Duration: 42 months

 

Partners

 NRCWE  Denmark
 RIVM  The Netherlands
 NIA  Belgium
 EMPA  Switzerland
 Gaiker  Spain
 Dialogik  Germany
 GreenDecision  Italy
 INERIS  France
 misvik  Finland
 AIRI  Italy
 Karolinska Institutet  Sweden
 NERC  United Kingdom
 DTU  Denmark
 National Health Laboratory Service  South Africa
 LEITAT  Spain
 Steinbeis  Germany
 Duke University  United States of America
 RTI International  United States of America
 eawag  Switzerland
 TNO  The Netherlands
 Tampere University of Technology  Finland
 FIOH  Finland
 University of Helsinki  Finland
 Ca’ Foscari University of Venice  Italy

Leave a Reply

Your email address will not be published.